Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer Therapy

9 Sept 2022

Abstract excerpt

The aim of our proposed concept is to find new target structures for combating cancers with unmet medical needs. This, unfortunately, still applies to the majority of the clinically most relevant tumor entities such as, for example, liver cancer, pancreatic cancer, and many others. Current target structures almost all belong to the class of oncogenic proteins caused by tumor-specific genetic alterations, such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cancer-related Molecular Pathways
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36139547
DOI: 10.3390/cancers14184386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer TherapyPMID 36139547Read ↗

Molecular pathways: protein methyltransferases in cancer.Semantic proximity Read ↗

Mechanism of activation and the rewired network: New drug design concepts.Semantic proximity Read ↗

Tumor suppressor genes: prospects for cancer therapies.Semantic proximity Read ↗

Loss of Tumor Suppressor Gene Function in Human Cancer: An OverviewSemantic proximity Read ↗

PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral MimicrySemantic proximity Read ↗

Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.Semantic proximity Read ↗

Two hits revisited again.Semantic proximity Read ↗

Covalent Rescue of Mutant p53Semantic proximity Read ↗

Strategy for "detoxification" of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2.Semantic proximity Read ↗

Induction of a SALL4-dependency for targeted cancer therapySemantic proximity Read ↗

Targeted protein posttranslational modifications by chemically induced proximity for cancer therapySemantic proximity Read ↗

Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.